AYGEN, B. Et Al. 2016. Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4. Asian Pacific Association for the Study of the Liver (APASL) .

AYGEN, B., YILDIZ, O., GÖKAHMETOĞLU, S., TAHERİ, S., & TÜRE, Z., (2016). Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4 . Asian Pacific Association for the Study of the Liver (APASL)

AYGEN, BİLGEHAN Et Al. "Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4," Asian Pacific Association for the Study of the Liver (APASL), 2016

AYGEN, BİLGEHAN Et Al. "Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4." Asian Pacific Association for the Study of the Liver (APASL) , 2016

AYGEN, B. Et Al. (2016) . "Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4." Asian Pacific Association for the Study of the Liver (APASL) .

@conferencepaper{conferencepaper, author={BİLGEHAN AYGEN Et Al. }, title={Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4}, congress name={Asian Pacific Association for the Study of the Liver (APASL)}, city={}, country={}, year={2016}}